Phenotypical features of a heterozygous form of familial hypercholesterolemia

被引:0
|
作者
Malyshev, P. P.
Rozhkova, T. A.
Solovyeva, E. Yu.
Meshkov, A. N.
Kaminnaya, V. I.
Kukharchuk, V. V.
机构
关键词
familial hypercholesterolemia; xanthomas; cholesterol;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To conduct a quantitative and qualitative analysis of phenotypical manifestations in patients with a heterozygous form of familial hypercholesterolemia (FHC) and to reveal factors involved in their development. Material and methods. A total of 247 patients with a clinical diagnosis of heterozygous FHC participated in the trial. Clinical manifestations of the disease in men and women were analysed and compared. Blood lipids were compared to those in the controls. A correlation analysis was used to reveal correlations between symptoms of the disease and lipid levels in the blood. Results. Tendon xanthomas were most frequent (79916) clinical sign with location primarily in Achilles' tendon. Incidence of basic clinical manifestations increased with age and significantly correlated with LDLP cholesterol. Two clinical signs were seen in 113 of the patients, three - in 13% (sex differences were insignificant). Mean levels of total cholesterol and LDLP serum cholesterol in heterozygous patients were 1.9 and 2.5 times higher than in the controls. Total cholesterol was significantly higher in women. A mean level of HDLP cholesterol was significantly lower while triglycerides were higher than in the control group. The disease symptoms manifested in men 5 years earlier than in women, FHC was diagnosed in men 7 5 years earlier. Conclusion. Patients with heterozygous FHC are characterized by higher levels of LDLP cholesterol, lower level of HDLP cholesterol and higher triglycerides in the serum than in healthy controls. Sex-related differences by severity and prevalence of basic symptoms in heterozygous FHC patients were not found. The time of clinical symptoms appearance and diagnosis evidences for more rapid progression of the disease in men.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [41] Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia
    Macpherson, Merran
    Hamren, Bengt
    Braamskamp, Marjet J. A. M.
    Kastelein, John J. P.
    Lundstrom, Torbjorn
    Martin, Paul D.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (01) : 19 - 27
  • [42] Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing
    Corral, Pablo
    Salinas, Carlos A. Aguilar
    Matta, Maria Gabriela
    Zago, Valeria
    Schreier, Laura
    CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (12) : 899 - 909
  • [43] Femoral atherosclerosis in heterozygous familial hypercholesterolemia influence of the genetic defect
    Junyent, Mireia
    Gilabert, Rosa
    Zambon, Daniel
    Pocovi, Miguel
    Mallen, Miguel
    Cofan, Montserrat
    Nunez, Isabel
    Civeira, Fernando
    Tejedor, Diego
    Ros, Emilio
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (03) : 580 - 586
  • [44] AORTIC COMPLIANCE IN YOUNG-PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    LEHMANN, ED
    WATTS, GF
    FATEMILANGROUDI, B
    GOSLING, RG
    CLINICAL SCIENCE, 1992, 83 (06) : 717 - 721
  • [45] Imaging biomarkers to track subclinical atherosclerosis in heterozygous familial hypercholesterolemia
    Miname, Marcio H.
    Santos, Raul D.
    CLINICAL LIPIDOLOGY, 2013, 8 (02) : 231 - 242
  • [46] Influence of β0-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia -: A study of patients with familial hypercholesterolemia from Sardinia
    Deiana, L
    Garuti, R
    Pes, GM
    Carru, C
    Errigo, A
    Rolleri, M
    Pisciotta, L
    Masturzo, P
    Cantafora, A
    Calandra, S
    Bertolini, S
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (01) : 236 - 243
  • [47] Heterozygous familial hypercholesterolemia: the first challenge for anti-PCSK9 monoclonal antibodies
    Zambon, Alberto
    GIORNALE ITALIANO DI CARDIOLOGIA, 2016, 17 (04) : 22S - 30S
  • [48] Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults
    Bellows, Brandon K.
    Khera, Amit, V
    Zhang, Yiyi
    Ruiz-Negron, Natalia
    Stoddard, Henry M.
    Wong, John B.
    Kazi, Dhruv S.
    de Ferranti, Sarah D.
    Moran, Andrew E.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (11):
  • [49] Defining Patients at Extremely High Risk for Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia
    Sugisawa, Takako
    Okamura, Tomonori
    Makino, Hisashi
    Watanabe, Makoto
    Kishimoto, Ichiro
    Miyamoto, Yoshihiro
    Iwamoto, Noriyuki
    Yamamoto, Akira
    Yokoyama, Shinji
    Harada-Shiba, Mariko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (04) : 369 - 375
  • [50] Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) - Results of a US national survey
    Block, Robert C.
    Bang, Matthew
    Peterson, Amy
    Wong, Nathan D.
    Karalis, Dean G.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (05) : 682 - 689